Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tramadol hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tramadol hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tramadol hydrochloride, quantity: 50 mg - capsule - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; sunset yellow fcf; quinoline yellow; allura red ac; potable water; gelatin; sodium lauryl sulfate - relief of moderate to severe pain. for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tramadol hydrochloride, quantity: 50 mg - capsule - excipient ingredients: maize starch; microcrystalline cellulose; lactose monohydrate; sodium starch glycollate; magnesium stearate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; sunset yellow fcf; quinoline yellow; allura red ac; potable water; gelatin; sodium lauryl sulfate - relief of moderate to severe pain. for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate dihydrate; hyprolose; colloidal anhydrous silica; magnesium stearate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; hyprolose; calcium hydrogen phosphate dihydrate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hyprolose; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; magnesium stearate - indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. not indicated for use in chronic non-cancer pain other than in exceptional circumstances. not indicated as an as-needed (prn) analgesia.

Singapore - English - HSA (Health Sciences Authority)

ids medical systems (singapore) pte ltd - general hospital - the disposable medical laryngeal mask is intended to be used to open and seal the upper throat, and provide ventilation passage in the patient's airway during autonomous, assisted, or controlled ventilation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

autono-med ltd -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

remedica ltd - risperidone - tablets film-coated - 1mg